SGMO vs. ABCL
Compare and contrast key facts about Sangamo Therapeutics, Inc. (SGMO) and AbCellera Biologics Inc. (ABCL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SGMO or ABCL.
Key characteristics
| SGMO | ABCL | |
|---|---|---|
| YTD Return | 277.32% | -53.59% |
| 1Y Return | 484.55% | -39.50% |
| 3Y Return (Ann) | -40.72% | -45.58% |
| Sharpe Ratio | 3.01 | -0.73 |
| Sortino Ratio | 3.55 | -0.97 |
| Omega Ratio | 1.40 | 0.90 |
| Calmar Ratio | 4.64 | -0.43 |
| Martin Ratio | 10.74 | -1.05 |
| Ulcer Index | 42.96% | 39.35% |
| Daily Std Dev | 153.36% | 56.63% |
| Max Drawdown | -99.40% | -95.94% |
| Current Drawdown | -95.87% | -95.50% |
Fundamentals
| SGMO | ABCL | |
|---|---|---|
| Market Cap | $564.28M | $874.28M |
| EPS | -$1.38 | -$0.61 |
| Total Revenue (TTM) | $2.88M | $32.96M |
| Gross Profit (TTM) | -$5.20M | -$59.24M |
| EBITDA (TTM) | -$133.70M | -$182.83M |
Correlation
The correlation between SGMO and ABCL is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SGMO vs. ABCL - Performance Comparison
In the year-to-date period, SGMO achieves a 277.32% return, which is significantly higher than ABCL's -53.59% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SGMO vs. ABCL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sangamo Therapeutics, Inc. (SGMO) and AbCellera Biologics Inc. (ABCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SGMO vs. ABCL - Dividend Comparison
Neither SGMO nor ABCL has paid dividends to shareholders.
Drawdowns
SGMO vs. ABCL - Drawdown Comparison
The maximum SGMO drawdown since its inception was -99.40%, roughly equal to the maximum ABCL drawdown of -95.94%. Use the drawdown chart below to compare losses from any high point for SGMO and ABCL. For additional features, visit the drawdowns tool.
Volatility
SGMO vs. ABCL - Volatility Comparison
Sangamo Therapeutics, Inc. (SGMO) has a higher volatility of 61.52% compared to AbCellera Biologics Inc. (ABCL) at 23.53%. This indicates that SGMO's price experiences larger fluctuations and is considered to be riskier than ABCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SGMO vs. ABCL - Financials Comparison
This section allows you to compare key financial metrics between Sangamo Therapeutics, Inc. and AbCellera Biologics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities